The future of bronchodilation: looking for new classes of bronchodilators

Mario Cazzola, Paola Rogliani, Maria Gabriella Matera

Source: Eur Respir Rev, 28 (154) 190095; 10.1183/16000617.0095-2019
Journal Issue: December
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mario Cazzola, Paola Rogliani, Maria Gabriella Matera. The future of bronchodilation: looking for new classes of bronchodilators. Eur Respir Rev, 28 (154) 190095; 10.1183/16000617.0095-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Are bronchodilator drugs really useful in COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 94s
Year: 2001

Is it time to move away from short-acting beta-agonists in asthma management?
Source: Eur Respir J, 53 (4) 1802223; 10.1183/13993003.02223-2018
Year: 2019

Long-acting bronchodilators in COPD: where are we now and where are we going?
Source: Breathe 2014; 10:110-120
Year: 2014

Therapeutic approaches beyond positive airway pressure and bronchodilators: time for rehabilitation?
Source: Sleep and Breathing Conference 2021
Year: 2021

A new class of bronchodilator improves lung function in COPD: a trial with GSK961081
Source: Eur Respir J 2013; 42: 972-981
Year: 2013

Emerging inhaled bronchodilators: an update
Source: Eur Respir J 2009; 34: 757
Year: 2009

An inhaled “bifunctional” dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD
Source: Eur Respir J, 52 (5) 1801675; 10.1183/13993003.01675-2018
Year: 2018

Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment
Source: Eur Respir J 2008; 31: 1145-1147
Year: 2008

Long-acting bronchodilators and synergistic interaction: a challenge across the currently available LABA/LAMA combinations
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

Inhaled beta2-agonists in asthma management: an evolving story
Source: Breathe 2016; 12: 375-377
Year: 2016

Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015

Switching to maintenance and reliever inhaled corticosteroid/long acting beta agonist: a real-world pilot evaluation in a regional paediatric difficult asthma clinic.
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020

Anti-asthmatic drugs: treatment of athletes and exercise-induced bronchoconstriction
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=73
Year: 2005

The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

Individual and differential treatment responses to once-daily long acting bronchodilators, glycopirronium and indacaterol, and combination of both drugs in the patients with moderate or severe COPD
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014

Inhaled therapies: can they breathe new life into asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

Inhaler preference comparing two alternative dual bronchodilator regimens
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016

The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 666s
Year: 2006